Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management of adverse reactions to biologic agents.

Allergy and asthma proceedings - 1 Nov 2017

Isabwe Ghislaine Annie C, de Las Vecillas Sanchez Leticia, Castells Mariana

Abstract excerpt

Hypersensitivity reactions (HSR) to targeted biologic agents present as immediate reactions during infusion or as delayed reactions (after one or more exposures). The new classification includes phenotypes, endotypes, and biomarkers. Phenotypes include immediate type I (immunoglobulin E [IgE] or non-IgE mediated), cytokine release, mixed (type I/cytokine), and immune complexes type III (IgG mediated) reactions as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Factors
Share to Biomarkers
Share to Desensitization, Immunologic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Hypersensitivity

Share to Phenotype

Source

Identifiers

PMID: 29046192
DOI: 10.2500/aap.2017.38.4085

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management of adverse reactions to biologic agents.PMID 29046192Read ↗

Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.Semantic proximity Read ↗

Drug hypersensitivity in the fast lane: What clinicians should know about phenotypes, endotypes, and biomarkers.Semantic proximity Read ↗

Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology.Semantic proximity Read ↗

Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.Semantic proximity Read ↗

From acute phase mediators to drug provocation testing: a single center experience in the allergy work-up of adverse drug reactions to chemotherapySemantic proximity Read ↗

Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms.Semantic proximity Read ↗

Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.Semantic proximity Read ↗

An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.Semantic proximity Read ↗

Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches.Semantic proximity Read ↗

Adverse cutaneous drug eruptions: current understanding.Semantic proximity Read ↗

Advances in Prognostic Biomarkers and Targeted Immunomodulation in Severe Cutaneous Adverse ReactionsSemantic proximity Read ↗

Delayed drug hypersensitivity reactions - new concepts.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.